Hepatic endosome protein profiling in Apolipoprotein E deficient mice expressing Apolipoprotein B48 but not B100

Journal of Bioanalysis and Biomedicine

Volumn 2, Issue 5, 2010, Pages 100-106

  Chen, AnShu ^a   Guo, ZhongMao ^a   Zhou, LiChun ^a   Yang, Hong ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Apolipoprotein B48; Apolipoprotein E; Endosomes; Lipoproteins; Proteomics

Indexed keywords

ADENOSINE TRIPHOSPHATE SYNTHASE CATALYTIC SUBUNIT A1; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; APOLIPOPROTEIN E; CALRETICULIN; CATHEPSIN B; CATHEPSIN D; CATHEPSIN H; CATHEPSIN X; CELL DIVISION CONTROL PROTEIN 2; CELL PROTEIN; DIPEPTIDYL PEPTIDASE II; HAPTOGLOBIN; HEMOPEXIN; MAJOR URINARY PROTEIN 6; PROTEIN DISULFIDE ISOMERASE; PROTEIN DISULFIDE ISOMERASE A1; PROTEIN DISULFIDE ISOMERASE A3; SOLUBLE N ETHYLMALEIMIDE SENSITIVE FACTOR ATTACHMENT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; FUNCTIONAL PROTEOMICS; LIVER CELL NUCLEUS; LIVER LYSOSOME; MEMBRANE FUSION; MOUSE; NONHUMAN; PLASMA CLEARANCE; PLASMA PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN TRANSPORT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 79952601271     PISSN: None     EISSN: 1948593X     Source Type: Journal    
DOI: 10.4172/1948-593X.1000031     Document Type: Article

References (37)

1. Alban A, David SO, Bjorkesten L, Andersson C, Sloge E, et al (2003) A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3: 36-44.
2. Anderson GJ, Frazer DM (2005) Hepatic iron metabolism. Semin Liver Dis 25: 420-432.
3. Bagshaw RD, Mahuran DJ, Callahan JW (2005) A proteomic analysis of lysosomal integral membrane proteins reveals the diverse composition of the organelle. Mol Cell Proteomics 4: 133-143.
4. Beg ZH, Stonik JA, Hoeg JM, Demosky SJ Jr, Fairwell T, et al. (1989) Human apolipoprotein A-I. Post-translational modification by covalent phosphorylation. J Biol Chem 264: 6913-6921.
5. Berriot-Varoqueaux N, Aggerbeck LP, Samson-Bouma M, Wetterau JR (2000) The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. Annu Rev Nutr 20: 663-697.
6. Berwin B, Delneste Y, Lovingood RV, Post SR, Pizzo SV (2004) SREC-I, a type F scavenger receptor, is an endocytic receptor for calreticulin. J Biol Chem 279: 51250-51257.
7. Casciola-Rosen LA, Renfrew CA, Hubbard AL (1992) Lumenal labeling of rat hepatocyte endocytic compartments. Distribution of several acid hydrolases and membrane receptors. J Biol Chem 267: 11856-11864.
8. Ellgaard L, Ruddock LW (2005) The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO Rep 6: 28-32.
9. Farese RV Jr, Véniant MM, Cham CM, Flynn LM, Pierotti V, et al.(1996) Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. Proc Natl Acad Sci U S A 93: 6393-6398.
10. Faust PL, Wall DA, Perara E, Lingappa VR, Kornfeld S (1987) Expression of human cathepsin D in Xenopus oocytes: phosphorylation and intracellular targeting. J Cell Biol 105: 1937-1945.
11. Flower DR (2000) Beyond the superfamily: the lipocalin receptors. Biochim Biophys Acta 1482: 327-336.
12. Forgac M (1998) Structure, function and regulation of the vacuolar (H+)-ATPases. FEBS Lett 440: 258-263.
13. Gelebart P, Opas M, Michalak M (2005) Calreticulin, a Ca2+-binding chaperone of the endoplasmic reticulum. Int J Biochem Cell Bio 37: 260-266.
14. Ghebrehiwet B, Peerschke EI (2004) cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection. Mol Immunol 41: 173-183.
15. Guo Z, Mitchell-Raymundo F, Yang H, Ikeno Y, Nelson J, et al. (2002) Dietary restriction reduces atherosclerosis and oxidative stress in the aorta of apolipoprotein E-deficient mice. Mech Ageing Dev 123: 1121-1131.
16. Hanewinkel H, Glössl J, Kresse H (1987) Biosynthesis of cathepsin B in cultured normal and I-cell fibroblasts. J Biol Chem 262: 12351-12355.
17. Havel RJ, Hamilton RL (2004) Hepatic catabolism of remnant lipoproteins: Where the action is. Arterioscler Thromb Vasc Biol 24: 213-215.
18. Heeren J, Grewal T, Jäckle S, Beisiegel U (2001) Recycling of apolipoprotein E and lipoprotein lipase through endosomal compartments in vivo. J Biol Chem. 276: 42333-42338.
19. Hubbard MJ, Mangum JE, McHugh NJ (2004) Purification and biochemical characterization of native ERp29 from rat liver. Biochem J 383: 589-597.
20. Hussain MM, Bakillah A, Jamil H (1997) Apolipoprotein B binding to microsomal triglyceride transfer protein decreases with increases in length and lipidation: implications in lipoprotein biosynthesis. Biochemistry 36: 13060-13067.
21. Ishidoh K, Kominami E (2002) Processing and activation of lysosomal proteinases. Biol Chem 383: 1827-1831.
22. Kimura H, Odani S, Nishi S, Sato H, Arakawa M (1991) Primary structure and cellular distribution of two fatty acid-binding proteins in adult rat kidneys. J Biol Chem 266: 5963-5972.
23. Magoori K, Kang MJ, Ito MR, Kakuuchi H, Ioka RX, et al. (2003) Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E. J Biol Chem 278: 11331-11336.
24. Mahley RW, Huang Y, Rall SC Jr (1999) Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J Lipid Res 40: 1933-1949.
25. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N (1992) Generation of mice carrying a mutatnt apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A 89: 4471-4475.
26. Qian C, Zhang Q, Wang X, Zeng L, Farooq A, et al. (2005) Structure of the adaptor protein p14 reveals a profilin-like fold with distinct function. J Mol Biol 347: 309-321.
27. Raftery M, Campbell R, Glaros EN, Rye KA, Halliday GM, et al. (2005) Phosphorylation of apolipoprotein-E at an atypical protein kinase CK2 PSD/E site in vitro. Biochemistry 44: 7346-7353.
28. Rhee SG, Chae HZ, Kim K (2005) Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38: 1543-1552.
29. Sakai J, Ishikawa H, Kojima S, Satoh H, Yamamoto S, et al. (2003) Proteomic analysis of rat heart in ischemia and ischemia-reperfusion using fluorescence twodimensional difference gel electrophoresis. Proteomics 3: 1318-1324.
30. Schwartz CC, VandenBroek JM, Cooper PS (2004) Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans. J Lipid Res 45: 1594-1607.
31. Skehel JM, Schneider K, Murphy N, Graham A, Benson GM, et al. (2000) Phenotyping apolipoprotein E*3-leiden transgenic mice by two-dimensional polyacrylamide gel electrophoresis and mass spectrometric identification. Electrophoresis 21: 2540-2545.
32. Stenmark, H, Zerial M (2001) Molecular mechanisms of membrane fusion in the endocytic pathway. M. Marsh, editor Endocytosis Oxford University Press In., New York 94-110.
33. Tubbs KA, Kiernan UA, Niederkofler EE, Nedelkov D, Bieber AL, et al. (2005) High-throughput MS-based protein phenotyping: application to haptoglobin. Proteomics 5: 5002-5007.
34. Vergés M, Castro A, Jaumot M, Bachs O, Enrich C (1997) Cyclin A is present in the endocytic compartment of rat liver cells and increases during liver regeneration. Biochem Biophys Res Commun. 230: 49-53.
35. Witzmann FA, Jarnot BM, Parker DN, Clack JW (1994). Modification of hepatic immunoglobulin heavy chain binding protein (BiP/Grp78) following exposure to structurally diverse peroxisome proliferators. Fundam Appl Toxicol 23: 1-8.
36. Wu D, Yang H, Xiang W, Zhou L, Shi M, et al. (2005) Heterozygous mutation of ataxia-telangiectasia mutated gene aggravates hypercholesterolemia in apoE-deficient mice. J Lipid Res 46: 1380-1387.
37. Yu KC, Jiang Y, Chen W, Cooper AD (2000) Rapid initial removal of chylomicron remnants by the mouse liver does not require hepatically localized apolipoprotein E. J Lipid Res 41: 1715-1727.